Profund Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
28,516
+9,245
| +48% | +$74.8K | 0.01% | 821 |
|
|
2025
Q1 | $161K | Sell |
19,271
-1,825
| -9% | -$15.3K | 0.01% | 927 |
|
|
2024
Q4 | $167K | Sell |
21,096
-1,762
| -8% | -$14K | 0.01% | 1035 |
|
|
2024
Q3 | $190K | Buy |
22,858
+336
| +1% | +$2.8K | 0.01% | 1061 |
|
|
2024
Q2 | $143K | Buy |
22,522
+1,680
| +8% | +$10.7K | 0.01% | 1023 |
|
|
2024
Q1 | $126K | Buy |
20,842
+2,836
| +16% | +$17.2K | ﹤0.01% | 1117 |
|
|
2023
Q4 | $109K | Buy |
+18,006
| New | +$109K | ﹤0.01% | 1098 |
|
|
2021
Q3 | – | Sell |
-11,333
| Closed | -$59K | – | 1354 |
|
|
2021
Q2 | $59K | Buy |
11,333
+873
| +8% | +$4.55K | ﹤0.01% | 1413 |
|
|
2021
Q1 | $70K | Buy |
+10,460
| New | +$70K | ﹤0.01% | 1335 |
|
|
2020
Q1 | – | Sell |
-10,351
| Closed | -$50K | – | 795 |
|
|
2019
Q4 | $50K | Buy |
+10,351
| New | +$50K | ﹤0.01% | 1257 |
|
|
2019
Q1 | – | Sell |
-16,688
| Closed | -$226K | – | 1214 |
|
|
2018
Q4 | $226K | Sell |
16,688
-2,879
| -15% | -$39K | 0.01% | 960 |
|
|
2018
Q3 | $434K | Buy |
+19,567
| New | +$434K | 0.02% | 925 |
|